Johns Hopkins Pathology Appointments 2nd Opinion Glossary Resources Get Involved! Giving
Pancreas Cancer
Understanding PC Research What's New? Discuss It! Personal Stories Coping Clinical Trials

 

Return to diagnostic techniques list

Fine needle aspiration (FNA)
 

A method to biopsy, obtain cells, for examination under the microsope.

FNA, performed in conjunction with a CT or MRI imaging, enables pathologists to determine the nature of a suspicious pancreatic abnormality.

Procedure:

It is a surprisingly safe procedure that involves passing a small needle directly through the skin or through an endoscope. The CT or MRI imaging allows the doctor to see where the needle is going. This is because the needle used has a very small bore. This sometimes means that the small amount of tissue obtained is insufficient for the pathologist to establish a diagnosis.

Accuracy:

The diagnosis of a pancreatic tumor based on a FNA is highly accurate, approaching 99%. However, it is only between 50-70% accurate in determining whether the tumor is benign or malignant.

Because the amount of tissue obtained is so small, the absence of malignant cells in the sample cannot exclude the possibility of malignant disease altogether.

Risks :

Complications such as bleeding or infection occur very rarely, less than 1% of patients.

<




     
 

We subscribe to the HONcode principles.
Verify here.

This site is supported by generous educational grants from the Vesalius Trust

Disclaimer: No two patients with pancreas cancer are identical. The appropriate treatment of individual patients with pancreatic cancer varies greatly depending on the patient's medical and surgical history. The information expressed in this Web page is not medical advice. It is meant only to educate health care professionals and patients about the current status of treatment and research in pancreas cancer at Hopkins. Before making any medical decisions, patients with pancreatic cancer are advised to consult with their personal physicians.